Genetic Testing May be Used to Identify BPH Patients With Increased Risk of Prostate Cancer, Tampere University Hospital Study
3/20/2013 7:59:03 AM
Patients with benign prostatic hyperplasia (BPH) carrying prostate cancer (PCa) a risk alleles are a potential target population for PCa screening and follow-up, according to a study, which was presented yesterday at the 28th Annual EAU Congress in Milan. The study aimed to evaluate the genetic predisposition of patients with BPH to developing prostate cancer, with findings suggesting that genetic testing may offer a new tool to identify BPH patients with increased risk to develop PrCa.
comments powered by